Search

Your search keyword '"T-Lymphocytes, Regulatory drug effects"' showing total 4,894 results

Search Constraints

Start Over You searched for: Descriptor "T-Lymphocytes, Regulatory drug effects" Remove constraint Descriptor: "T-Lymphocytes, Regulatory drug effects"
4,894 results on '"T-Lymphocytes, Regulatory drug effects"'

Search Results

1. The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials.

2. Direct effects of heroin and methadone on T cell function.

3. SPH7854, a gut-limited RORγt antagonist, ameliorates TNBS-induced experimental colitis in rat.

4. Electroacupuncture and methotrexate cooperate to ameliorate psoriasiform skin inflammation by regulating the immune balance of Th17/Treg.

5. Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.

6. Mitigation of checkpoint inhibitor-induced autoimmune hemolytic anemia through modulation of purinergic signaling.

7. Eldecalcitol ameliorates diabetic osteoporosis and glucolipid metabolic disorder by promoting Treg cell differentiation through SOCE.

8. Interleukin-2 improves insulin sensitivity through hypothalamic sympathetic activation in obese mice.

9. Retinoic Acid (RA): A Critical Immunoregulatory Molecule in Asthma and Allergies.

10. Bioactive compounds from ShenFuShanYuRou decoction enhance Treg cell function against hemorrhagic shock injury via Stat1- and Gbp5-dependent FOXP3 induction.

11. Effects of Ruxolitinib on Immune Checkpoint Molecule Expression in JAK2 V617F-Positive Cells.

12. IDO1 inhibitors are synergistic with CXCL10 agonists in inhibiting colon cancer growth.

13. Anti-inflammatory effects of phytocannabinoids and terpenes on inflamed Tregs and Th17 cells in vitro.

14. Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE -/- Mice.

15. HSP90β shapes the fate of Th17 cells with the help of glycolysis-controlled methylation modification.

16. Bergapten enhances mitophagy to regulate intestinal barrier and Th17/Treg balance in mice with Crohn's disease-like colitis via PPARγ/NF-κB signaling pathway.

17. IL-35 promotes IL-35 + IL-10 + Bregs and Conventional LAG3 + Tregs in the lung tissue of OVA-Induced Asthmatic Mice.

18. Effects of dietary Chitosan oligosaccharides supplementation on Th17/Treg balance and gut microbiota of early weaned pigeon squabs.

19. Suppressive Role of Pigment Epithelium-derived Factor in a Rat Model of Corneal Allograft Rejection.

20. Alleviated diabetic osteoporosis and peripheral neuropathic pain by Rehmannia glutinosa Libosch polysaccharide via increasing regulatory T cells.

21. Erythropoietin induces tumour progression and CD39 expression on immune cells in a preclinical model of triple-negative breast cancer.

22. The alterations in CD4 + Treg cells across various phases of major depression.

23. Dihydroartemisinin ameliorates experimental autoimmune myasthenia gravis by regulating CD4 +  T cells and modulating gut microbiota.

24. Tryptophan-rich diet and its effects on Htr7 + Tregs in alleviating neuroinflammation and cognitive impairment induced by lipopolysaccharide.

25. Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity.

26. Epigenetic modification of CD4 + T cells into Tregs by 5-azacytidine as cellular therapeutic for atherosclerosis treatment.

27. Nanoreactors with Cascade Catalytic Activity Reprogram the Tumor Microenvironment for Enhanced Immunotherapy by Synchronously Regulating Treg and Macrophage Cells.

28. Percutaneous Delivery of Hederacoside C-Loaded Nanoliposome Gel Alleviates Psoriasiform Skin Inflammation through the CCL17/Treg Axis.

29. The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.

30. Quercetin ameliorates celiac-related intestinal inflammation caused by wheat gluten through modulating oxidative stress, Th1/Th2/Treg balance, and intestinal microflora structure.

31. Da-Jian-Zhong decoction alleviates diarrhea-predominant irritable bowel syndrome via modulation of gut microbiota and Th17/Treg balance.

32. VX-509 (Decernotinib)-modified tolerogenic dendritic cells alleviate experimental autoimmune neuritis by promoting Th17/Treg rebalance.

33. Harnessing immune cells to leverage PARP inhibitors.

34. Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors.

35. Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models.

36. Regulatory T Cells Nanoextinguisher to Manipulate Multiple Immune Evasion for Immunotherapy.

37. Simvastatin alleviates experimental autoimmune encephalomyelitis through regulating the balance of Th17 and Treg in mice.

38. Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.

39. Mechanism of Prunella vulgaris L. and luteolin in restoring Tfh/Tfr balance and alleviating oxidative stress in Graves' disease.

40. Selenium nanoparticles enhance the anti-tumor immune responses of anti-4-1BB antibody and alleviate the adverse effects on mice.

41. The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.

42. Beneficial effects of Dendrobium officinale National Herbal Drink on metabolic immune crosstalk via regulate SCFAs-Th17/Treg.

43. Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody.

44. N-acetyl cysteine augments adipose tissue-derived stem cell efficacy on inflammatory markers and regulatory T cell system balance in an allergic asthma model.

45. Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis.

46. Zinc dampens antitumor immunity by promoting Foxp3 + regulatory T cells.

47. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients.

48. Deferoxamine preconditioning of canine stem cell derived extracellular vesicles alleviates inflammation in an EAE mouse model through STAT3 regulation.

49. Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells.

50. Antioxidant and Immunomodulatory Polymer Vesicles for Effective Diabetic Wound Treatment through ROS Scavenging and Immune Modulating.

Catalog

Books, media, physical & digital resources